Riskpilot← Back to searchSign inGet full accessWellbinista AB
ABActiveOrg 5592618234Mölnavägen 5Other non-specialised retail sale · NACE 4712Est. 20202 employees
Revenue 2024
SEK 0
EBITDA margin
—
+56% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -9K
+60% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -10K | +56% |
| Net profit | SEK -9K | +60% |
| Total assets | SEK 43K | -19% |
| Equity | SEK 43K | -18% |
| Employees | 2 | — |
Legal name
Wellbinista AB
Org number
5592618234
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
2 juli 2020
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget erbjuder ett noga utvalt sortiment av hälsoprodukter med hög kvalitet via en modern plattform för e-handel. Kund- erbjudandet utgörs av ett brett utbud av hälsoprodukter inom kosttillskott, vitaminer, naturlig hudvård och intim- och hygienprodukter. Detta kombineras med stort fokus på digital service samt tillförlitlig leverans.
Address
Mölnavägen 5
Email
annapersonne@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | — | 0 | 2 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −38 | −8 | −23 | −10 |
| Depreciation & amort. | −0 | −0 | — | −0 |
| EBIT | −38 | −8 | −23 | −10 |
| Net financials | — | — | 0 | — |
| Profit before tax | −38 | −8 | −22 | −9 |
| Tax | −0 | −0 | — | −0 |
| Net profit | −38 | −8 | −22 | −9 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 47 | 55 | 53 | 43 |
| Equity | 42 | 55 | 53 | 43 |
| Long-term debt | 0 | 0 | — | 0 |
| Short-term debt | 5 | 0 | 0 | 0 |
| Total debt | 5 | — | 0 | — |
EBITDA margin
-1000000.0%
This company
15.8%
Market median
-6329214% vs market
20212024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212024
Return on equity
-20.9%
This company
18.4%
Market median
-214% vs market
20212024
Net profit margin
-900000.0%
This company
8.1%
Market median
-11111211% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AU Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wellbinista AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Ulrika Personne | Chief Executive Officer | 0 companies |
| Brita Ulrika Personne | Chairman | 0 companies |
| Lina Victoria Gabrielson | Chairman | 0 companies |